Doherty Catherine T.
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Doherty Catherine T.. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| DGX | EVP, Regional Businesses | Sale | 5,370 | $174.13 | $935,078 | Mar 5, 2025 |
| DGX | EVP, Regional Businesses | Tax Withholding | 394 | $173.74 | $68,454 | Mar 4, 2025 |
| DGX | EVP, Regional Businesses | Tax Withholding | 455 | $171.75 | $78,146 | Feb 27, 2025 |
| DGX | EVP, Regional Businesses | Sale | 535 | $169.71 | $90,795 | Feb 20, 2025 |
| DGX | EVP, Regional Businesses | Award / Grant | 3,479 | — | — | Feb 12, 2025 |
| DGX | EVP, Regional Businesses | Option Exercise | 33,103 | $103.57 | $3,428,478 | Nov 27, 2024 |
| DGX | EVP, Regional Businesses | Sale | 1,187 | $125.88 | $149,420 | Feb 28, 2024 |
| DGX | EVP, Regional Businesses | Award / Grant | 9,314 | $125.02 | $1,164,436 | Feb 23, 2024 |
| DGX | EVP, Regional Businesses | Tax Withholding | 493 | $125.02 | $61,635 | Feb 22, 2024 |
| DGX | SVP, Regional Businesses | Award / Grant | 4,304 | — | — | Feb 14, 2024 |
| DGX | SVP, Regional Businesses | Tax Withholding | 4,610 | $147.86 | $681,635 | Mar 6, 2023 |
| DGX | SVP, Regional Businesses | Sale | 717 | $140.63 | $100,832 | Mar 3, 2023 |
| DGX | SVP, Regional Businesses | Tax Withholding | 392 | $140.69 | $55,150 | Mar 1, 2023 |
| DGX | SVP, Regional Businesses | Sale | 1,690 | $141.42 | $239,000 | Feb 23, 2023 |
| DGX | SVP, Regional Businesses | Sale | 17,358 | $148.92 | $2,584,953 | Nov 28, 2022 |
| DGX | SVP, Group Exec. Clin. Fran. | Tax Withholding | 6,360 | $130.09 | $827,372 | Mar 8, 2022 |
| DGX | SVP, Group Exec. Clin. Fran. | Sale | 2,750 | $126.26 | $347,215 | Feb 24, 2022 |
| DGX | SVP, Group Exec. Clin. Fran. | Tax Withholding | 1,082 | $130.09 | $140,757 | Feb 23, 2022 |
| DGX | SVP, Group Exec. Clin. Fran. | Sale | 15,908 | $156.86 | $2,495,329 | Nov 29, 2021 |
| DGX | SVP, Group Exec. Clin. Fran. | Sale | 8,536 | $139.96 | $1,194,699 | May 7, 2021 |
| DGX | SVP, Group Exec. Clin. Fran. | Award / Grant | 11,299 | $115.42 | $1,304,131 | Mar 9, 2021 |
| DGX | SVP, Group Exec. Clin. Fran. | Tax Withholding | 796 | $121.15 | $96,435 | Feb 24, 2021 |
| DGX | SVP, Group Exec. Clin. Fran. | Award / Grant | 3,941 | — | — | Feb 17, 2021 |
| DGX | SVP, Group Exec. Clin. Fran. | Sale | 54,616 | $110.57 | $6,038,891 | Sep 2, 2020 |
| DGX | SVP, Group Exec. Clin. Fran. | Tax Withholding | 2,517 | $106.46 | $267,960 | Mar 10, 2020 |
| DGX | SVP, Group Exec. Clin. Fran. | Tax Withholding | 777 | $112.90 | $87,723 | Feb 26, 2020 |
| DGX | SVP, Group Exec. Clin. Fran. | Tax Withholding | 356 | $113.34 | $40,349 | Feb 24, 2020 |
| DGX | SVP, Group Exec. Clin. Fran. | Award / Grant | 4,012 | — | — | Feb 18, 2020 |
| DGX | SVP, Group Exec. Clin. Fran. | Sale | 60,492 | $90.59 | $5,479,970 | Apr 4, 2019 |
| DGX | SVP, Group Exec. Clin. Fran. | Tax Withholding | 3,777 | $86.86 | $328,070 | Mar 1, 2019 |
| DGX | SVP, Group Exec. Clin. Fran. | Tax Withholding | 1,066 | $87.84 | $93,637 | Feb 26, 2019 |
| DGX | SVP, Group Exec. Clin. Fran. | Tax Withholding | 363 | $88.24 | $32,031 | Feb 25, 2019 |
| DGX | SVP, Group Exec. Clin. Fran. | Tax Withholding | 336 | $88.39 | $29,699 | Feb 22, 2019 |
| DGX | SVP, Group Exec. Clin. Fran. | Award / Grant | 3,348 | — | — | Feb 18, 2019 |
| DGX | SVP, Group Exec. Clin. Fran. | Sale | 5,556 | $101.00 | $561,156 | Mar 2, 2018 |
| DGX | SVP, Group Exec. Clin. Fran. | Sale | 572 | $104.99 | $60,054 | Feb 27, 2018 |
| DGX | SVP, Group Exec. Clin. Fran. | Sale | 397 | $102.74 | $40,788 | Feb 23, 2018 |
| DGX | SVP, Group Exec. Clin. Fran. | Award / Grant | 2,897 | — | — | Feb 19, 2018 |
| DGX | SVP, Group Exec. Clin. Fran. | Sale | 21,294 | $104.00 | $2,214,576 | Jan 24, 2018 |
| DGX | SVP, Group Exec. Clin. Fran. | Option Exercise | 44,000 | $57.61 | $2,534,840 | Jun 19, 2017 |
| DGX | SVP, Group Exec. Clin. Fran. | Gift | 4,740 | — | — | May 19, 2017 |
| DGX | SVP, Group Exec. Clin. Fran. | Tax Withholding | 6,492 | $98.12 | $636,995 | Mar 2, 2017 |
| DGX | SVP, Group Exec. Clin. Fran. | Tax Withholding | 585 | $96.42 | $56,406 | Feb 28, 2017 |
| DGX | SVP, Group Exec. Clin. Fran. | Tax Withholding | 638 | $95.68 | $61,044 | Feb 24, 2017 |
| DGX | SVP, Group Exec. Clin. Fran. | Award / Grant | 3,132 | — | — | Feb 21, 2017 |
| DGX | SVP, Clin. Franchise Solutions | Sale | 1,615 | $94.65 | $152,860 | Feb 15, 2017 |
| DGX | SVP, Clin. Franchise Solutions | Tax Withholding | 1,740 | $93.85 | $163,299 | Feb 13, 2017 |
| DGX | SVP, Clin. Franchise Solutions | Sale | 37,414 | $90.40 | $3,382,226 | Jan 30, 2017 |
| DGX | SVP, Clin. Franchise Solutions | Option Exercise | 23,667 | $55.65 | $1,317,069 | May 27, 2016 |
| DGX | SVP, Clin. Franchise Solutions | Option Exercise | 23,667 | $51.20 | $1,211,750 | Apr 25, 2016 |